leading to short stature and delayed puberty. A novel recombinant human growth hormone,somatrogon-ghla, has been approved to treat growth failure in pediatric patients with growth hormone deficiency. This long-acting agent is injected subcutaneously once a week, thereby reducing injection frequency...